We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Nanogen and Fisher to Expand Reach into Molecular Diagnostics
News

Nanogen and Fisher to Expand Reach into Molecular Diagnostics

Nanogen and Fisher to Expand Reach into Molecular Diagnostics
News

Nanogen and Fisher to Expand Reach into Molecular Diagnostics

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Nanogen and Fisher to Expand Reach into Molecular Diagnostics "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Nanogen, Inc. has announced that Fisher Scientific International Inc. has agreed to purchase approximately 5.7 million shares of Nanogen common stock at $2.65 per share.

Nanogen will use the proceeds from the sale for working capital, acquisitions and other general corporate purposes.

The investment in Nanogen coincides with Fisher's purchase of Athena Diagnostics, Inc. Nanogen and Fisher will collaborate to expand the use of Athena's proprietary markers and diagnostic assays.

"We are very pleased to initiate this relationship with Fisher," said Howard C. Birndorf, chairman and CEO of Nanogen.

"Fisher shares our vision of developing diagnostic technologies and products for personalized medicine."

"This is yet another indication that molecular diagnostics for personalized healthcare is gaining momentum and being adopted by mainstream diagnostic laboratories."

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.

All of the shares of common stock were offered to Fisher Scientific International Inc. pursuant to an effective registration statement that was filed on June 28, 2005.

Advertisement